Descemet Membrane Endothelial Keratoplasty in Toxic Anterior Segment Syndrome: A Case Series
dc.contributor.author | Necip, Kara | |
dc.contributor.author | Oltulu, Refik | |
dc.contributor.author | Levent, Dogan | |
dc.contributor.author | Osman, Gundogan Ali | |
dc.date.accessioned | 2024-02-23T14:21:10Z | |
dc.date.available | 2024-02-23T14:21:10Z | |
dc.date.issued | 2021 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Purpose: To evaluate the outcomes of Descemet membrane endothelial keratoplasty (DMEK) in patients with toxic anterior segment syndrome (TASS). Methods: Thirteen eyes of 13 patients who underwent DMEK for endothelial decompensation secondary to TASS were retrospectively reviewed. A comprehensive ocular examination including best-corrected visual acuity (BCVA), slitlamp biomicroscopy, intraocular pressure measurement, fundus evaluation, and measurement of central corneal thickness were performed in all patients at preoperatively and postoperatively. Results: There were 8 men and 5 women, with an average age of 56 +/- 19 years. The mean follow-up was 8.7 +/- 3.5 months. The time interval between the onset of TASS and DMEK was 4.9.+/- 6.6 months (range, 1.5-26 months). Twelve of 13 grafts were clear at last visit. The mean preoperative BCVA was 20/666 (range, hand motion to 20/200), and the mean BCVA was 20/36 (range, hand motion to 20/20) at the postoperative last visit (P = 0.003). The decrease in mean pachymetry from preoperative (768 +/- 69 mu m) to postoperative last visit (523 +/- 71 mu m) was statistically significant (P < 0.001). Conclusions: DMEK seems to be a safe and an effective treatment option in eyes with TASS-related endothelial decompensation. | en_US |
dc.identifier.doi | 10.1097/ICO.0000000000002524 | |
dc.identifier.endpage | 1010 | en_US |
dc.identifier.issn | 0277-3740 | |
dc.identifier.issn | 1536-4798 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 33009092 | en_US |
dc.identifier.scopus | 2-s2.0-85111789202 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 1007 | en_US |
dc.identifier.uri | https://doi.org/10.1097/ICO.0000000000002524 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/13464 | |
dc.identifier.volume | 40 | en_US |
dc.identifier.wos | WOS:000711685000012 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Cornea | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Toxic Anterior Segment Syndrome | en_US |
dc.subject | Corneal Edema | en_US |
dc.subject | Endothelial Keratoplasty | en_US |
dc.title | Descemet Membrane Endothelial Keratoplasty in Toxic Anterior Segment Syndrome: A Case Series | en_US |
dc.type | Article | en_US |